Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7943115 | 0.90 | ALDH1A1 (0.59) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL29785519 | 0.89 | ALDH1A1 (0.70) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL6240718 | 0.89 | ALDH1A1 (0.70) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL30504387 | 0.87 | KMT2A (0.52) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL12293443 | 0.87 | HPGD (0.52) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL23861345 | 0.86 | ESR1 (0.59) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL12293438 | 0.85 | ALDH1A1 (0.50) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL12293445 | 0.85 | ALDH1A1 (0.50) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL23861494 | 0.83 | ESR1 (0.66) | ALDH1A1TDP1HPGDHSD17B10ALOX15 | |
| SCHEMBL17500131 | 0.83 | MEN1 (0.50) | ALDH1A1TDP1HPGDHSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110065804-A1 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2011-03-17 | — | — | US | claimed |
| WO-2009120784-A2 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2009-10-01 | — | — | WO | claimed |
| WO-2002050002-A1 | NON-HALOGENATED PHENYL SUBSTITUTED PHENOLS, ANTIMICROBIAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | WARNER-LAMBERT COMPANY LLC (US) | 2002-06-27 | — | — | WO | claimed |
| US-20190257049-A1 | Methods and Apparatus for Stabilization of Surfaces | Polylast Systems, LLC | 2019-08-22 | — | — | US | disclosed |
| US-10309070-B2 | Methods and apparatus for stabilization of surfaces | Polylast Systems, LLC (US) | 2019-06-04 | — | — | US | disclosed |
| US-9982143-B2 | Methods and apparatus for stabilization of surfaces | Polylast Systems, LLC (US) | 2018-05-29 | — | — | US | disclosed |
| US-20170002533-A1 | Methods and Apparatus for Stabilization of Surfaces | KING COAST INC. | 2017-01-05 | — | — | US | disclosed |
| US-20160333192-A1 | Methods and Apparatus for Stabilization of Surfaces | KING COAST INC. | 2016-11-17 | — | — | US | disclosed |
| US-8609892-B2 | Glucagon receptor antagonists, preparation and therapeutic uses | ELI LILLY AND COMPANY (US) | 2013-12-17 | — | — | US | disclosed |
| US-20110124648-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2011-05-26 | — | — | US | disclosed |
| US-20110065804-A1 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2011-03-17 | — | — | US | disclosed |
| EP-1758853-B1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | LILLY CO ELI (US) | 2010-01-20 | — | — | EP | disclosed |
| WO-2009120784-A2 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2009-10-01 | — | — | WO | disclosed |
| US-20070249688-A1 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses | ELI LILLY AND COMPANY (US) | 2007-10-25 | — | — | US | disclosed |
| US-7211700-B2 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | MCNEIL-PPC, INC. (US) | 2007-05-01 | — | — | US | disclosed |
| EP-1758853-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-03-07 | — | — | EP | disclosed |
| WO-2005123668-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2005-12-29 | — | — | WO | disclosed |
| US-20050239903-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | MCNEIL-PPC, INC | 2005-10-27 | — | — | US | disclosed |
| US-20030207945-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2003-11-06 | — | — | US | disclosed |
| US-20020119106-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2002-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207945-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | TYR, CLPP, PTPN1 | ALDH1A1 3007/4885TDP1 3314/4885HPGD 2481/4885 |
| US-20110124648-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | GLP1R, GCGR, GIPR | ALDH1A1 3337/4885TDP1 4706/4885HPGD 1855/4885 |
| US-20070249688-A1 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses | GLP1R, GCGR, GIPR | ALDH1A1 3337/4885TDP1 4706/4885HPGD 1855/4885 |
| US-20050239903-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | TYR, CLPP, PTPN1 | ALDH1A1 3007/4885TDP1 3314/4885HPGD 2481/4885 |
| US-20020119106-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | TYR, CLPP, PTPN1 | ALDH1A1 3007/4885TDP1 3314/4885HPGD 2481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.